Zentralbl Chir 2021; 146(S 01): S80
DOI: 10.1055/s-0041-1733443
Abstracts

V-212 Additional Lobectomy for Empyema Stage 3 with concurrent Lobe Destruction – A surgical Option?

A Moschovas
1   Uniklinikum Jena, Department of Cardiothoracic Surgery, University Hospital Jena, Germany, Jena, Deutschland
,
T Sandhaus
1   Uniklinikum Jena, Department of Cardiothoracic Surgery, University Hospital Jena, Germany, Jena, Deutschland
,
K Abdyvasiev
1   Uniklinikum Jena, Department of Cardiothoracic Surgery, University Hospital Jena, Germany, Jena, Deutschland
,
M Steinert
2   Uniklinikum Leipzig, Department of Visceral, Transplant, Thoracic, and Vascular Surgery University Hospital Leipzig, Leipzig, Deutschland
,
T Doenst
1   Uniklinikum Jena, Department of Cardiothoracic Surgery, University Hospital Jena, Germany, Jena, Deutschland
› Author Affiliations
› Further Information
Also available at
 

Hintergrund

Treatment outcomes of empyema Stage 3 have been described in the literature over the years. However, surgical outcomes in patients with concurrent lobe destruction, where an additional lobectomy is needed, are not well reported, despite an existing incidence up to 20%. We assessed our results with lobectomy plus decortication (LD) in comparison with decortication alone (D).



Publication History

Article published online:
06 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany